Solution Stability - Plasma, Gastrointestinal, Bioassay

被引:23
作者
Di, Li [1 ]
Kerns, Edward H. [1 ]
机构
[1] Wyeth Ayerst Res, Princeton, NJ 08543 USA
关键词
Plasma stability; solution stability; simulated gastro-intestinal fluids; stability-ph profile; high throughput; drug discovery; HPLC; LC-MS;
D O I
10.2174/138920008786485218
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Solution stability of drug candidates in plasma, gastrointestinal fluids and bioassays is important in order to achieve low clearance, good oral bioavailability and have robust SAR. Screening of solution stability early in drug discovery can avoid pursuing hits with high risk of instability, prioritize chemical series, guide structural modification, and enhance the chance of project success. The conditions of solution stability methods are critical in generating relevant data and include: test compound concentration, enzyme source and preparation, limits of solubility, cosolvent, plasma protein binding effect, detection techniques (LC-UV vs. LC-MS), and what to detect ( disappearance of parent vs. formation of degradants). Details of methodologies, applications, structure-stability relationships and case studies are discussed.
引用
收藏
页码:860 / 868
页数:9
相关论文
共 56 条
[1]   Gastric pH profiles of beagle dogs and their use as an alternative to human testing [J].
Akimoto, M ;
Nagahata, N ;
Furuya, A ;
Fukushima, K ;
Higuchi, S ;
Suwa, T .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 49 (02) :99-102
[2]  
[Anonymous], 2003, HYDROLYSIS DRUG PROD
[3]   A new approach to evaluate stability of amodiaquine and its metabolite in blood and plasma [J].
Blessborn, D ;
Neamin, G ;
Bergqvist, Y ;
Lindegårdh, N .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 41 (01) :207-212
[4]   Design and synthesis of pyrrolidine-5,5′-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease.: 4.: Antiviral activity and plasma stability [J].
Borthwick, AD ;
Davies, DE ;
Ertl, PF ;
Exall, AM ;
Haley, TM ;
Hart, GJ ;
Jackson, DL ;
Parry, NR ;
Patikis, A ;
Trivedi, N ;
Weingarten, GG ;
Woolven, JM .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (21) :4428-4449
[5]   Structure-based optimization of novel azepane derivatives as PKB inhibitors [J].
Breitenlechner, CB ;
Wegge, T ;
Berillon, L ;
Graul, K ;
Marzenell, M ;
Friebe, WG ;
Thomas, U ;
Schumacher, R ;
Huber, R ;
Engh, RA ;
Masjost, B .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (06) :1375-1390
[6]   EFFECTS OF 3 REPUTED CARBOXYLESTERASE INHIBITORS UPON RAT SERUM ESTERASE-ACTIVITY [J].
CHAMBERS, JP ;
HARTGRAVES, SL ;
MURPHY, MR ;
WAYNER, MJ ;
KUMAR, N ;
VALDES, JJ .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1991, 15 (01) :85-88
[7]   Gastric pH and gastric residence time in fasted and fed conscious cynomolgus monkeys using the Bravo® pH system [J].
Chen, Emile P. ;
Doan, Kelly M. Mahar ;
Portelli, Samm ;
Coatney, Robert ;
Vaden, Vernal ;
Shi, Wei .
PHARMACEUTICAL RESEARCH, 2008, 25 (01) :123-134
[8]   Stabilizing drug molecules in biological samples [J].
Chen, Jiwen ;
Hsieh, Yunsheng .
THERAPEUTIC DRUG MONITORING, 2005, 27 (05) :617-624
[9]   Stability study of the designer drugs "MDA, MDMA and MDEX" in water, serum, whole blood, and urine under various storage temperatures [J].
Clauwaert, KM ;
Van Bocxlaer, JF ;
De Leenheer, AP .
FORENSIC SCIENCE INTERNATIONAL, 2001, 124 (01) :36-42
[10]   SPECIES-DEPENDENT ESTERASE-ACTIVITIES FOR HYDROLYSIS OF AN ANTI-HIV PRODRUG GLYCOVIR AND BIOAVAILABILITY OF ACTIVE SC-48334 [J].
COOK, CS ;
KARABATSOS, PJ ;
SCHOENHARD, GL ;
KARIM, A .
PHARMACEUTICAL RESEARCH, 1995, 12 (08) :1158-1164